randomized controlled trial

A randomized controlled trial examined whether remotely delivered live exercise classes work better than pre-recorded exercise training for people with chronic low back pain. The study adds to ongoing debate about telehealth: whether real-time supervision improves adherence and outcomes, or whether on-demand video sessions offer equal benefit with more convenience for patients and clinics.

A randomized, double-blind controlled trial tested 12 months of vitamin C supplementation in 109 people with precancerous or cancerous blood disorders who were not receiving chemotherapy. Researchers found that growth of (pre)cancerous cells was unchanged in the treatment group, though the supplemented group reported fewer cases of anemia. The findings suggest vitamin C does not halt disease progression but may offer modest supportive benefits.

A randomized, double-blind, placebo-controlled trial published in Nature tested safiglipron, an oral small-molecule GLP-1 receptor agonist, in people with early type 2 diabetes. Unlike injectable GLP-1 drugs such as semaglutide, safiglipron is taken as a pill, which could make treatment easier to access. The publication is drawing attention as drugmakers race to develop oral alternatives to popular injectable weight and diabetes medications.

A new randomized controlled trial in neuromodulation is being described as raising the methodological standard for the field, with its use of brain-wave outcomes drawing attention among clinicians and researchers. The trial suggests future studies in brain stimulation may need to incorporate objective neurophysiological measures rather than relying solely on clinical endpoints. Details of the trial's sponsor, condition treated and results are not yet clear.